| Trial Identifier: | D601HC00009 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel
|
| NCTID:: | NCT04949425 |
| Start Date: | September 2021 |
| Primary Completion Date: | April 2022 |
| Study Completion Date: | April 2022 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| English (UK) Translation | |
| Spanish (Spain) Translation | |
| Spanish (US) Translation |
| Country | Location |
|---|---|
| ES | Barcelona, ES, 8023 |
| ES | Madrid, ES, 28029 |
| ES | Madrid, ES, 28041 |
| ES | Madrid, ES, 28031 |
| ES | Madrid, ES, 28040 |
| ES | Madrid, ES, 28034 |
| ES | Malaga, ES, 29010 |
| ES | Pozuelo de Alarcon, ES, 28223 |
| GB | London, GB, W12 0HS |
| GB | Manchester, GB, M20 4BX |
| GB | Wirral, GB, CH63 4JY |
| US, CT | New Haven, CT, US, 06510 |
| US, GA | Newnan, GA, US, 30265 |
| US, MI | Farmington Hills, MI, US, 48334 |
| US, NH | Lebanon, NH, US, 03756 |
| US, OH | Cincinnati, OH, US, 45267 |
| US, OR | Portland, OR, US, 97213 |
| US, TX | Austin, TX, US, 78758 |
| US, TX | Dallas, TX, US, 75230 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company